Venus Concept to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 28, 2022
February 02, 2022 07:30 ET
|
Venus Concept Inc.
TORONTO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and...
Venus Concept Receives FDA 510(k) Clearance of Venus BlissMAX for Non-Invasive Lipolysis of the Abdomen and Flanks, Cellulite Reduction and Muscle Conditioning
January 18, 2022 16:05 ET
|
Venus Concept Inc.
TORONTO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it has received...
Venus Concept Reports Preliminary Revenue Results for Fourth Quarter 2021
January 10, 2022 07:00 ET
|
Venus Concept Inc.
TORONTO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudited...
Venus Concept Announces $17 Million Equity Financing led by Masters Special Situations
December 15, 2021 09:00 ET
|
Venus Concept Inc.
TORONTO, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has completed a...
Venus Concept Announces Third Quarter and First Nine Months of 2021 Financial Results; Updates Fiscal Year 2021 Revenue Guidance
November 12, 2021 07:00 ET
|
Venus Concept Inc.
TORONTO, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the...
Venus Concept Inc. to Participate in the Stifel 2021 Virtual Healthcare Conference
November 10, 2021 16:05 ET
|
Venus Concept Inc.
TORONTO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will...
Venus Concept Receives FDA 510(k) Clearance for the Venus Freedom™
October 19, 2021 07:30 ET
|
Venus Concept Inc.
TORONTO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received...
Venus Concept Appoints Ross J. Portaro as President of Global Sales
October 12, 2021 07:30 ET
|
Venus Concept Inc.
TORONTO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the appointment of Ross...
Venus Concept to Release Third Quarter of Fiscal Year 2021 Financial Results on November 12, 2021
October 04, 2021 16:05 ET
|
Venus Concept Inc.
TORONTO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that third quarter of fiscal...
Venus Concept Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 07, 2021 16:05 ET
|
Venus Concept Inc.
TORONTO, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will...